gingival hyperplasia


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to gingival hyperplasia: gingivitis

gin·gi·val hy·per·pla·si·a

gingival enlargement due to proliferation of fibrous connective tissue.

gin·gi·val hy·per·pla·si·a

(jinji-văl hīpĕr-plāzē-ă)
Enlargement of gums due to proliferation of fibrous connective tissue.
Synonym(s): gingival proliferation.

gin·gi·val hy·per·pla·si·a

(jinji-văl hīpĕr-plāzē-ă)
Enlargement of gums due to proliferation of fibrous connective tissue.
Synonym(s): gingival proliferation.
References in periodicals archive ?
Periodontal surgery, good oral hygiene practice and regular dental visits showed successful results for the treatment of gingival hyperplasia in the present case.
Kaposi sarcoma can be seen as oral lesion (palate and gingiva) after renal transplantation, and it is important to know that in oral presentation, Kaposi sarcoma may mimic gingival hyperplasia. The etiology of the disease is unknown, although Kaposi sarcoma has been strongly related to immunosuppression and human herpes virus 8 (37).
The periodontal disorder with gingival hyperplasia was seen in lambs and kids both in winter and summer lambing seasons.
The following parameters were recorded: age; sex; Loe and Sillness Plaque Index, amlodipine dosage, duration and gingival hyperplasia, using the grading system described by Angelopoulos and Goaz 1972 (Grade 0: No signs of gingival enlargement, Grade 1: Enlargement confined to interdental papilla, Grade 2: Enlargement involves papilla and marginal gingival, Grade 3: Enlargement involves three quarters or more of the crown) (Figure 1, 2 and 3).
Gingival hyperplasia as a first manifestation of Crohn's disease.
Clinical assessment of gingival hyperplasia in patients treated with nifedipine.
It is characterized by papular and nodular skin lesions, gingival hyperplasia, joint contractures and bone involvement in variable degrees 1.
Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol.
It has been estimated that 25-80% of patients on a regimen of CsA experience gingival hyperplasia (Lawrence et al., 1994), an overgrowth of gingival tissue resulting from an inhibition of normal apoptotic pathways.
Drug-induced gingival overgrowth (DIGO) is previously termed as gingival hypertrophy or gingival hyperplasia by finding an increased number of fibroblasts in gingival connective tissues [1].
(14,15) Although the presence of myofibroblasts has been reported in hereditary gingival fibromatosis (16) and drug-induced gingival hyperplasia, (17,18) few studies have evaluated its presence in focal reactive overgrowths of the gingiva.
Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1972; 34:898-906.